Are Systematic Screening for Vitamin D Deficiency and Vitamin D Supplementation Currently Feasible for Ankylosing Spondylitis Patients?

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Life stage group</td><td class="align_left">Loading dose</td><td class="align_center">Maintenance dose</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">0-1 year</td><td class="align_left">2000 IU/day or 50000 IU/week for 6 weeks</td><td class="align_center">400–1000 IU/day</td></tr><tr><td class="align_left">1–18 years</td><td class="align_left">2000 IU/day or 50000 IU/week for at least 6 weeks</td><td class="align_center">600–1000 IU/day</td></tr><tr><td class="align_left">Adults</td><td class="align_left">6000 IU/day or 50000 IU/week for 8 weeks</td><td class="align_center">1500–2000 IU/day</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td>IU: international units.<br/></td></tr></table>

Vitamin D (vitamin D<sub>2</sub> and vitamin D<sub>3</sub>) treatment for vitamin D deficiency as recommended by the Endocrine Society for the treatment of vitamin D deficiency.

International Journal of Inflammation

tab2

Table 2

Table 2: Are Systematic Screening for Vitamin D Deficiency and Vitamin D Supplementation Currently Feasible for Ankylosing Spondylitis Patients? 